---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-036548"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:25:08.252408+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# QHSLab doubles assessment completions to ~50K year-to-date; two abstracts accepted at ACAAI

## Summary
- Platform processed ~50,000 assessments in 2024 YTD, more than double the same period in 2023.
- Two abstracts accepted for presentation at ACAAI conference in Boston; two more submitted for 2025 APA meeting.
- R&D focusing on AI-driven digital tools for allergic rhinitis, anxiety, depression, chronic pain.
- Preliminary findings from health journeys series show reduced depression, anxiety, pain, allergy scores after few months.
- Company continues to integrate digital medicine to reduce non-clinical burden on providers.

## SEC filing metadata
- accession: 0001493152-24-036548
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315224036548/0001493152-24-036548-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315224036548/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-036548
- JSON: https://secwatch.observer/filing/0001493152-24-036548.json
- Plain text: https://secwatch.observer/filing/0001493152-24-036548.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.